TMDX: TransMedics Expected earnings per share growth for next year
TransMedics Group (TMDX) has monopolized the organ preservation market through aviation logistics and unique systems, ensuring a steady inflow of capital. An impeccable reputation in transplantology guarantees the trust of the world's leading surgeons. The consensus for next year's earnings per share indicates that the parameter value is 49.10. Aggressive hiring of perfusionists and staff expansion confirm the potential for further business scaling.
Analytical breakdowns for TransMedics (TMDX)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital TransMedics Group|TMDX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital TransMedics Group, Inc.|TMDX - Company Total Debt Obligations|Debts to Book Capitalization TransMedics|TMDX - Company Long-Term Liabilities|Company Short-Term Debts TransMedics|Quick Liquidity transmedics.com
- net income and valuation ratios data:
TMDX - Company Net Income|Future Profit TransMedics Group|TMDX - Company Value to Net Income|Forward P/E Multiple TransMedics Organ Care System|TMDX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics|TMDX - Operating profit before depreciation charges|Net earnings per share for the last 12 months TransMedics|TMDX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth transmedics.com|TMDX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year TransMedics Group
Initial company analysis:TransMedics Corp, TMDX
For a TransMedics Group (TMDX) investor, the asset's fundamental value is determined by management's ability to scale profits amid non-cyclical demand for transplantation equipment. An analysis of net income per share expectations reflects the institutional consensus forecast for future returns; while growth in this metric confirms business expansion, buying at the chart's peak values creates the risk of overpaying for the optimism already priced in.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|ATEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year AORT|ENOV (Enovis) - Earnings growth forecast for next year|Integra LifeSciences Corp (IART) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ESTA|Expected earnings per share growth for next year iLet Bionic Pancreas BBNX|Earnings growth forecast for next year IRMD (IRADIMED CORPORATION)|Earnings growth forecast for next year embecta.com EMBC|TNDM - Net earnings per share growth forecast for next year|AXGN: Net earnings per share growth forecast for next year|SIBN (SI-BONE Corp) - Expected earnings per share growth for next year|Orthofix Corp - Expected earnings per share trend next year|BVS (Bioventus Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year OrthoPediatrics Inc. KIDS|Net earnings per share growth forecast for next year Treace Medical Concepts, Inc. (TMCI)|Blade Air Mobility (SRTA) - Net earnings per one share growth forecast for next year|Carlsmed Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year RxSight Ophthalmic RXST|ClearPoint - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year stereotaxis.com STXS|Neuronetics (STIM) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year SGHT (Sight Sciences Inc.)|Net earnings per share growth forecast for next year Orchestra BioMed, Inc.|Expected earnings per share growth for next year Anika (ANIK)|Earnings growth forecast for next year NSPR|ZJYL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Vivani Medical VANI|XTNT: Projected earnings per share growth rate for next year|NMTC: Expected earnings per share growth for next year|Modular Medical - Projected earnings per share increase next year|MYO (Myomo, Inc.) - Expected earnings per share growth for next year|COCH: Projected earnings per share increase next year|Net earnings per share growth forecast for next year Vivos Therapeutics, Inc.|NVNO: Expected earnings per share trend next year|Earnings growth forecast for next year SINT|Earnings growth forecast for next year Tenon Medical Inc (TNON)|Net earnings per share growth forecast for next year ReWalk Robotics Ltd. LFWD|AMIX: Projected earnings per share growth rate for next year|IVF - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Bone Biologics Corp. BBLG|Axonics Modulation Technologies (AXNX) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Biolase Inc.|DYNT (Dynatronics Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Paragon 28 Corp FNA|Earnings growth forecast for next year INVO
